Overview
Log10 / Everest develops agentic clinical and regulatory workflows for life-sciences organizations.
What Log10 / Everest does
Log10 develops Everest, an AI platform for clinical and regulatory work in life sciences. It helps pharmaceutical, biotechnology and medical-device teams prepare documents and keep related material connected as new evidence becomes available.
Clinical-trial workflows cover protocols, investigator brochures, consent material, amendments, safety reports, patient narratives and clinical study reports. The system supports source-linked review and proposes changes across the document lifecycle rather than treating every deliverable as an unrelated draft.
Alongside the platform, Log10’s applied AI team builds custom systems and improves existing deployments. That work includes evaluation, cross-model review, human feedback and integration within the customer’s environment. Enterprise deployment options include additional isolation and VPC arrangements.
Company details
- Headquarters
- San Francisco, California, United States
- Funding
- $7.2 million seed (April 2024)
Founders & leadership
Investors & backers
Log10 announced $7.2M in seed funding on April 24, 2024, led by TQ Ventures and Quiet Capital.
- TQ Ventures
- Quiet Capital
- Essence Venture Capital







